Activated Effector and Memory T Cells Contribute to Circulating sCD30: Potential Marker for Islet Allograft Rejection
Open Access
- 1 September 2008
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 8 (9) , 1798-1808
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Soluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantationTransplant Immunology, 2008
- Post-Transplant HLA class II Antibodies and High Soluble CD30 Levels are Independently Associated with Poor Kidney Graft SurvivalAmerican Journal of Transplantation, 2007
- Elevated Soluble CD30 Correlates with Development of Bronchiolitis Obliterans Syndrome Following Lung TransplantationTransplantation, 2006
- Prognostic Values of Soluble CD30 and CD30 Gene Polymorphisms in Heart TransplantationTransplantation, 2006
- Pre-transplant Soluble CD30 Is Associated With Bronchiolitis Obliterans Syndrome After Lung TransplantationThe Journal of Heart and Lung Transplantation, 2006
- Alloantibody Production is Regulated by CD4+ T Cells' Alloreactive Pathway, Rather Than Precursor Frequency or Th1/Th2 DifferentiationAmerican Journal of Transplantation, 2004
- CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 responseTransplant Immunology, 2003
- CD30 in Normal and Neoplastic CellsClinical Immunology, 1999
- Expression of both Th1 and Th2 cytokines correlates with the histological rejection of MHC‐matched and MHC‐mismatched foetal pancreas allografts in miceImmunology & Cell Biology, 1997
- Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's diseaseCell, 1992